Genetic testing
Genetic testing, usually via a blood sample, is used to try and identify which gene contains the fault that is causing an individual’s sight loss.
Search
Search results
Flipping the switch on RP: SparingVision doses patients in their first in-human clinical trial for SPVN20
The latest research news from Retina UK.
On the run and under pressure
Imagine, if you can, evading capture from an elite team of hunters for 21 days when you’re blind! Ste and his co-fugitive, Chris, did just that in the new series of Hunted (Channel 4) which starts on Sunday 12 October.
Phase 3 clinical trial has been given approval by FDA
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
New mechanism of disease discovered for Retinitis Pigmentosa
The team have found the cause of disease in the first ever family tree drawn up at Moorfields Eye Hospital over 35 years ago, which had remained unsolved until now.
Financial support for young people attending conference
Financial support for young people attending conference
National Peer Support Group
Tuesday 31 March 2026, 7.00pm - 8.00pm - via Zoom - Please come and join us for our Spring meeting where we are delighted to welcome our guest speaker Stuart Hann, The Blind Chocolatier who runs his own business and shop in the Lake District!
‘Talking’ Tech Peer Support Group
Tuesday 24 March 2026, 7.00pm - 8.00pm - via Zoom - Join us for our latest meeting where we are delighted to introduce Anna Holloway & Ellie Dowdy as our new facilitators of the Tech group alongside our guest speaker Chris Moreton from HumanWare.